| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Asthma Phenotypes as a Guide for Current and Future Biologic Therapies
|
Hamilton, Daniel
|
|
|
59 |
2 |
p. 160-174
|
article
|
| 2 |
Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends
|
Gao, Lixia
|
|
|
59 |
2 |
p. 175-194
|
article
|
| 3 |
Correction to: Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions
|
Harish, Aasha
|
|
|
59 |
2 |
p. 273
|
article
|
| 4 |
Current and Future Monoclonal Antibodies in the Treatment of Atopic Dermatitis
|
Chun, Peter Ip Fung
|
|
|
59 |
2 |
p. 208-219
|
article
|
| 5 |
Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment
|
Choudhury, Shelly
|
|
|
59 |
2 |
p. 150-159
|
article
|
| 6 |
Immunologic Adverse Effects of Biologics for the Treatment of Atopy
|
Aranez, Vivian
|
|
|
59 |
2 |
p. 220-230
|
article
|
| 7 |
Targeted Anti-IL-5 Therapies and Future Therapeutics for Hypereosinophilic Syndrome and Rare Eosinophilic Conditions
|
Harish, Aasha
|
|
|
59 |
2 |
p. 231-247
|
article
|
| 8 |
The Current State of Biologic Therapies for Treatment of Refractory Asthma
|
Mavissakalian, Matthew
|
|
|
59 |
2 |
p. 195-207
|
article
|
| 9 |
Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
|
Agarwal, Aarti
|
|
|
59 |
2 |
p. 141-149
|
article
|
| 10 |
Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
|
Jiang, Jiao
|
|
|
59 |
2 |
p. 248-272
|
article
|
Journal description